HomeNewsBusinessPay cuts likely but there won't be any layoffs: Zoho Corporation CEO Sridhar Vembu

Pay cuts likely but there won't be any layoffs: Zoho Corporation CEO Sridhar Vembu

Vembu felt that the Software-as-a-Service (SaaS) segment is expected to consolidate, but recovery would be slow.

April 30, 2020 / 15:52 IST
Story continues below Advertisement

Zoho Corporation has halted employee bonuses and has not ruled out a pay cut in the future "if required", company CEO Sridhar Vembu said. He however stated that at "no cost" any employee would be given the pink slip.

"The impact of COVID-19 on our business is not as bad as we feared, though we are still in April. I have prepared our staff for a very tough time ahead,” Vembu told Business Standard, adding that bonuses have been cancelled.

Story continues below Advertisement

“But we have not pruned salaries … we may have to be prepared for a pay cut though … nobody can predict anything. But at any cost we want to avoid layoffs," he added.

On work from home (WFH), he said that even once curbs are lifted, Zoho would likely continue keeping 50-70 percent of staff on WFH as precaution. “The virus is not going to go away so quickly,” he added.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show